Obesity: an Underappreciate Risk Factor for Severe Form of COVID-19

Sponsor
Mohammed VI University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05771857
Collaborator
(none)
415
1
19
21.8

Study Details

Study Description

Brief Summary

Our study has the objective of identifying the epidemiological profil of the patients, as well as, the clinical, radiological and prognosis of obese patients with covid 19.

Condition or Disease Intervention/Treatment Phase
  • Device: Obesity

Detailed Description

Introduction: COVID 19 pandemic continues to progress with a considerable mortality and morbidity throughout the world since its emergence in December 2019. Many studies were conducted to identify the predictive factors of mortality of those infected with the virus. The previous studies noticed that obesity seems to be associated with severe form of respiratory distress syndrome. Our study has the objective of identifying the epidemiological profil of the patients, as well as, the clinical, radiological and prognosis of obese patients with covid 19.

Methods: investigators led a retrospective monocentric, descriptive and analytic study, in the department of anesthesia and intensive care unit of the university hospital of Mohamed VI Oujda, in Morocco, from March 2020 to October 2021, including all the patients tested positive for the infection.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
415 participants
Observational Model:
Cohort
Time Perspective:
Other
Official Title:
Obesity: an Underappreciate Risk Factor for Severe Form of COVID-19: Retrospective Cohort Study of 415 Cases
Actual Study Start Date :
Mar 1, 2020
Actual Primary Completion Date :
Sep 30, 2021
Actual Study Completion Date :
Oct 1, 2021

Outcome Measures

Primary Outcome Measures

  1. Obesity: An underappreciate risk factor for severe form of COVID-19: Retrospective cohort study of 415 cases [in all the 22 mounths]

    Is obesity a predictive factor of need of intensive care, in addition to the mortality of covid 19?

  2. Risk factor for severe form of COVID-19 [in all the 22 mounths]

    identify the epidemiological profil of the patients, as well as, the clinical, radiological and prognosis of obese patients with covid 19.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • All patients presenting an infection with SARS-CoV-2 that were hospitalized in the intensive care unit.
Exclusion Criteria:
  • None

Contacts and Locations

Locations

Site City State Country Postal Code
1 younes Oujidi Berkane Morocco 9999

Sponsors and Collaborators

  • Mohammed VI University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Younes Oujidi, Doctor, Mohammed VI University Hospital
ClinicalTrials.gov Identifier:
NCT05771857
Other Study ID Numbers:
  • Service anesthesie Reanimation
First Posted:
Mar 16, 2023
Last Update Posted:
Mar 16, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 16, 2023